Germany | Imports and Exports | World | Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
| Commodity | Reporter | Partner | Trade flow | Indicator | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
| 3002. Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc | Germany | World | Exports | Value (US$) | 19,594,592,042.00 | 20,785,801,413.85 | 22,337,767,316.90 | 21,985,347,794.71 | 22,818,473,375.06 | 24,885,055,686.34 | 29,414,651,106.54 | 29,093,777,261.80 | 33,477,293,703.83 | 48,922,062,959.49 | 45,736,828,702.10 | 46,729,695,193.45 |
| Value Growth, YoY (%) | 12.99 | 6.07 | 7.46 | -1.57 | 3.78 | 9.05 | 18.20 | -1.09 | 15.06 | 46.13 | -6.51 | 2.17 | ||||
| Imports | Value (US$) | 15,819,726,319.00 | 17,323,104,168.25 | 18,819,885,123.08 | 17,586,285,886.58 | 18,588,262,323.43 | 23,063,018,815.82 | 24,527,538,979.58 | 23,948,843,856.77 | 28,750,720,190.50 | 41,847,547,988.16 | 42,254,378,069.97 | 36,566,904,972.01 | |||
| Value Growth, YoY (%) | -6.67 | 9.50 | 8.64 | -6.55 | 5.69 | 24.07 | 6.35 | -2.35 | 20.05 | 45.55 | 0.97 | -13.46 |
The value of exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from Germany totalled $ 46 billion in 2023. Sales of commodity group 3002 from Germany went up by 2.17% compared to 2022: exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" went up by $ 992 million (cumulative exports of commodity group 3002 from Germany amounted $45 billion in 2022)
Exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" amounted to 2.75% of total exports from Germany (cumulative merchandise exports from Germany totalled $ 1.69 trillion in 2023). The share of commodity group 3002 in total exports from Germany increased by 0.04 p.p. compared to 2022 (it was 2.71% in 2022 and cumulative exports from Germany were equal to $ 1.68 trillion).
Exports of commodity group 3002 amounted to 38% of total sales of group "" from Germany in 2023 (the value of exports of commodity group from Germany amounted to $120 billion in 2023). The share of exports of commodity group 3002 in sales of commodity group from Germany increased by 2.51 p.p. compared to 2022 (it was 36% in 2022, and exports of commodity group from Germany were $126 billion).
Where does Germany export Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc?
Top export destinations of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from Germany in 2023:
- USA with a share of 30% (14 billion US$)
- Netherlands with a share of 10% (4.7 billion US$)
- Switzerland with a share of 7.91% (3.69 billion US$)
- Italy with a share of 5.79% (2.7 billion US$)
- France with a share of 4.37% (2.04 billion US$)
- Belgium with a share of 3.23% (1.51 billion US$)
- Japan with a share of 3.22% (1.5 billion US$)
- United Kingdom with a share of 2.96% (1.38 billion US$)
- China with a share of 2.85% (1.33 billion US$)
- Austria with a share of 2.63% (1.23 billion US$)
Exports structure of 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc - from Germany in 2023 represented by the following main commodity groups:
- 0.059% (27 million US$): 300290 - Human blood; animal blood prepared for therapeutic/prophylactic/diagnostic uses; toxins, cultures of micro-organisms (excl. yeasts) & sim. products
The value of imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to Germany totalled $ 36 billion in 2023. Sales of commodity group 3002 to Germany decreased by 13.4% in value terms compared to 2022. imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" decreased by $ 5.68 billion (the value of imports of commodity group 3002 to Germany was equal to $42 billion in 2022)
Imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" accounted for 2.48% of total import flow to Germany (in 2023, total imports to Germany amounted to $ 1.46 trillion). The share of commodity group 3002 in total imports to Germany decreased by 0.17 p.p. compared to 2022 (it was 2.65% in 2022 and cumulative imports to Germany were equal to $ 1.58 trillion).
Imports of commodity group 3002 reached 48% of total imports of group "" to Germany in 2023 (imports of commodity group to Germany totalled $74 billion in 2023). The share of purchases of commodity group 3002 in imports of commodity group to Germany went down by 2.74 p.p. compared to 2022 (it was 51% in 2022, and imports of commodity group to Germany accounted for $81 billion).
Where does Germany import Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc from?
Top trading partners (import of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc") of Germany in 2023:
- USA with a share of 19.8% (7.24 billion US$)
- Switzerland with a share of 17.8% (6.53 billion US$)
- Netherlands with a share of 13.8% (5.06 billion US$)
- Belgium with a share of 11.9% (4.36 billion US$)
- Ireland with a share of 11.5% (4.24 billion US$)
- France with a share of 5.74% (2.1 billion US$)
- Austria with a share of 4.63% (1.69 billion US$)
- Sweden with a share of 2.62% (959 million US$)
- Italy with a share of 2.29% (837 million US$)
- Korea with a share of 1.75% (640 million US$)
Imports structure of 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc - to Germany in 2023 represented by the following main commodity groups:
- 0.06% (22 million US$): 300290 - Human blood; animal blood prepared for therapeutic/prophylactic/diagnostic uses; toxins, cultures of micro-organisms (excl. yeasts) & sim. products
